ID

11850

Beskrivning

Epoetin Alfa Biosimilar in the Management of Chemotherapy-Induced Symptomatic Anemia in Haematology and Oncology; ODM derived from: https://clinicaltrials.gov/show/NCT02140736

Länk

https://clinicaltrials.gov/show/NCT02140736

Nyckelord

  1. 2015-08-10 2015-08-10 - Julian Varghese
Uppladdad den

10 augusti 2015

DOI

För en begäran logga in.

Licens

Creative Commons BY 4.0

Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Itemgroup-kommentar för :

Item-kommentar för :


Inga kommentarer

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Eligibility Chemotherapy-induced Symptomatic Anemia NCT02140736

Eligibility Chemotherapy-induced Symptomatic Anemia NCT02140736

Inclusion Criteria
Beskrivning

Inclusion Criteria

patients of more than 18 years of age
Beskrivning

patients of more than 18 years of age

Datatyp

boolean

Alias
UMLS CUI [1]
C0001779
patients presenting with anemia following chemotherapy
Beskrivning

patients presenting with anemia following chemotherapy

Datatyp

boolean

Alias
UMLS CUI [1]
C3665472
UMLS CUI [2]
C0002871
patients suffer from solid tumours, malignant hemopathies, lymphomas or myelomas and presenting with anemia following chemotherapy
Beskrivning

patients suffer from solid tumours, malignant hemopathies, lymphomas or myelomas and presenting with anemia following chemotherapy

Datatyp

boolean

Alias
UMLS CUI [1]
C0280100
UMLS CUI [2]
C3665472
UMLS CUI [3]
C0376545
- the patients may be included regardless of their chemotherapy cycle (from the first cycle until the last cycle)
Beskrivning

- the patients may be included regardless of their chemotherapy cycle (from the first cycle until the last cycle)

Datatyp

boolean

patients eligible for epoetin alfa biosimilar treatment
Beskrivning

patients eligible for epoetin alfa biosimilar treatment

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0013893
UMLS CUI [1,2]
C0357126
Exclusion Criteria
Beskrivning

Exclusion Criteria

patients are not receiving chemotherapy
Beskrivning

patients are not receiving chemotherapy

Datatyp

boolean

Alias
UMLS CUI [1]
C3665472
patients already included in an epoetin zeta trial
Beskrivning

patients already included in an epoetin zeta trial

Datatyp

boolean

Alias
UMLS CUI [1,1]
C2242969
UMLS CUI [1,2]
C1997870
patients presenting with a contraindication to epoetin zeta
Beskrivning

patients presenting with a contraindication to epoetin zeta

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0522473
UMLS CUI [1,2]
C1997870
patients presenting with hypersensitivity to the active principle or any of the excipients
Beskrivning

patients presenting with hypersensitivity to the active principle or any of the excipients

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0014822
patient with erythroblastopenia or acquired pure red cell aplasia (aprca)
Beskrivning

patient with erythroblastopenia or acquired pure red cell aplasia (aprca)

Datatyp

boolean

Alias
UMLS CUI [1]
C0877221
UMLS CUI [2]
C0340961
patient with uncontrollable arterial hypertension
Beskrivning

patient with uncontrollable arterial hypertension

Datatyp

boolean

Alias
UMLS CUI [1]
C1868885
patients who cannot receive adequate prophylaxis by antithrombotic agents
Beskrivning

patients who cannot receive adequate prophylaxis by antithrombotic agents

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0522473
UMLS CUI [1,2]
C1704311

Similar models

Eligibility Chemotherapy-induced Symptomatic Anemia NCT02140736

Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
age
Item
patients of more than 18 years of age
boolean
C0001779 (UMLS CUI [1])
Chemotherapy | Anemia | Hematologic Neoplasms
Item
patients presenting with anemia following chemotherapy
boolean
C3665472 (UMLS CUI [1])
C0002871 (UMLS CUI [2])
Solid tumour | Chemotherapy | Hematologic Neoplasms
Item
patients suffer from solid tumours, malignant hemopathies, lymphomas or myelomas and presenting with anemia following chemotherapy
boolean
C0280100 (UMLS CUI [1])
C3665472 (UMLS CUI [2])
C0376545 (UMLS CUI [3])
patient inclusion regardless of chemotherapy
Item
- the patients may be included regardless of their chemotherapy cycle (from the first cycle until the last cycle)
boolean
Eligibility Determination; Epoetin Alfa
Item
patients eligible for epoetin alfa biosimilar treatment
boolean
C0013893 (UMLS CUI [1,1])
C0357126 (UMLS CUI [1,2])
Chemotherapy
Item
patients are not receiving chemotherapy
boolean
C3665472 (UMLS CUI [1])
clinical trial participant (history); epoetin zeta
Item
patients already included in an epoetin zeta trial
boolean
C2242969 (UMLS CUI [1,1])
C1997870 (UMLS CUI [1,2])
Contraindication; epoetin zeta
Item
patients presenting with a contraindication to epoetin zeta
boolean
C0522473 (UMLS CUI [1,1])
C1997870 (UMLS CUI [1,2])
Hypersensitivity; Erythropoietin
Item
patients presenting with hypersensitivity to the active principle or any of the excipients
boolean
C0020517 (UMLS CUI [1,1])
C0014822 (UMLS CUI [1,2])
Decreased erythroid precursor production | Acquired red cell aplasia
Item
patient with erythroblastopenia or acquired pure red cell aplasia (aprca)
boolean
C0877221 (UMLS CUI [1])
C0340961 (UMLS CUI [2])
Uncontrolled hypertension
Item
patient with uncontrollable arterial hypertension
boolean
C1868885 (UMLS CUI [1])
Contraindication; Antithrombotic Agents
Item
patients who cannot receive adequate prophylaxis by antithrombotic agents
boolean
C0522473 (UMLS CUI [1,1])
C1704311 (UMLS CUI [1,2])

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial